⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036
globenewswire.com
NVO
LLY
HLF
WW
MDT
AMGN
PFE
AZN
JNJ
BSX
BMRN
REGN
BMY
ABBV
MRK
GSK
XRAY
SYK
ISRG
GOOG
MSFT
AMZN
NVDA
IBM
ORCL
COST
CVS
UNH
ELV
CI
HIMS
NE
ABT
BNED
DAN
MDLZ
PEP
CPB
SBUX
BNTX
CRSP
EDIT
NTLA
ALNY
GILD
BIIB
VRTX
SNOW
DDOG
CRM
PLTR
AI
UPST
COIN
MARA
RIOT
PLUG
FCEL
ENPH
SEDG
PLD
EQIX
AMAT
LRCX
KLAC
ASML
MU
WDC
SE
MELI
JD
BABA
NTES
BIDU
IQ
VIPS
NIO
XPEV
LI
TSLA
RBLX
GOOGL
META
AMD
INTC
QCOM
NXPI
MRVL
ADSK
CDNS
SNPS
MCHP
ADI
ON
NXST
FOX
CMCSA
NFLX
PARA
AMC
LULU
NKE
UA
PTON
EA
TTWO
BILI
PDD
BEKE
EDU
TAL
DAO
CLSK
HUT
BTBT
CAN
CRON
ACB
TLRY
OGI
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
globenewswire.com
HIMS
Class Action Filing Alert for Hims & Hers Health, Inc. (HIMS): Kahn Swick & Foti, LLC Advises Shareholders With Major Losses to Take Action
accessnewswire.com
HIMS
Kaplan Fox Announces a Securities Class Action Filed Against Hims & Hers Health, Inc. (NYSE:HIMS) - Lead Plaintiff Deadline is November 2, 2026
accessnewswire.com
HIMS
HIMS November 2, 2026 Lead Plaintiff Deadline - Robbins LLP Reminds Investors About the Opportunity to Lead the Class Action Lawsuit
globenewswire.com
HIMS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
prnewswire.com
HIMS
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
HIMS
Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline
prnewswire.com
HIMS
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
globenewswire.com
NVO
LLY
HIMS
ENHA
Kaplan Fox Continues to Remind Hims & Hers Health, Inc. (NYSE:HIMS) Investors of the Lead Plaintiff Deadline on November 2, 2026
accessnewswire.com
HIMS